Blog

Clinical trial consent: Using automation to get it right —every time Clinical Trial Sample and Consent Tracking BioFortis Clinical trial consent: Using automation to get it right —every time
“We have 20,000 samples and don’t know what they’re for or where they’re from!”
Clinical trial sample and consent tracking in the Digital Age Clinical Trial Sample and Consent Tracking Labmatrix BioFortis Clinical trial sample and consent tracking in the Digital Age
Moving from pen and paper to automated tech
PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer Genomics Wendell Jones, Ph.D. PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
NAR Cancer article, with contributions from Wendell Jones, PhD, Q2 Solutions GenomicsUterine serous carcinoma (USC), an aggressive variant of endometrial cancer representing approximately 10% of...
What are the key ingredients for a best practice R&D approach for tackling infectious disease? Infectious Diseases Patrice Hugo, Ph.D. What are the key ingredients for a best practice R&D approach for tackling infectious disease?
With a renewed interest in vaccine research and development (R&D), stakeholders across the industry are rethinking their approach to the field. Biopharmaceutical companies have growing numbers of...
Balancing R&D for Disease X and common illnesses Infectious Diseases Vaccines Patrice Hugo, Ph.D. Balancing R&D for Disease X and common illnesses
Stakeholders from across the industry, including biopharmaceutical companies, governments, and non-profit organizations, are rethinking their pandemic readiness in light of the COVID-19 pandemic,...
The Genesis of the Estimated Glomerular Filtration Rate (eGFR) Central Laboratories Steven Lobel, PhD, D-ABMLI, MBA, FACB The Genesis of the Estimated Glomerular Filtration Rate (eGFR)
In the beginning there was urine, creatinine and 3-liter jugs.
Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity Genomics Wendell Jones, Ph.D. Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity
Scientific Data article, with contributions from Wendell Jones, PhD, Q2 Solutions Genomics
Awarded as one of the Top 10 Clinical Trial Service Management companies Clinical Trials Central Laboratories Life Sciences Review Awarded as one of the Top 10 Clinical Trial Service Management companies
With state-of-the-art laboratory testing services, next-generation technology, and agile solutions tailored to meet the diverse needs of our clientele around the world, it's no coincidence that Life...
BioFortis: a data-driven approach to streamlining clinical trial samples Clinical Trials David Kaye BioFortis: a data-driven approach to streamlining clinical trial samples
Clinical trials can be envisioned as an ecosystem of laboratories, vendors, and biobanks knitted together by patient samples and data. Tracking patient samples and consent across this highly complex...
Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA Next Generation Sequencing Wendell Jones, Ph.D. Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA
Cell Reports Methods article authored by Wendell Jones